Form 4 for EW Edwards Lifesciences
Accepted 2026-05-05 19:05:08 ET · period of report 2026-05-03 · accession 0001225208-26-004968 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 19:05 | 2026-05-03 | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $83.98 | -515 | 80.8K | -0.6% | -$43.2K | |
| 2026-05-05 19:05 | 2026-05-05 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -523 | 80.3K | -0.6% | $0 | |
| I | 2026-05-05 19:05 | 2026-05-05 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +523 | 12.0K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-03 | F | D | 515 | $83.98 | 80,780.65 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-05 | G | D | 523 | $0.00 | 80,257.65 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-05 | G | A | 523 | $0.00 | 12,039.55 | I By Trust | — | — |